%20(1).webp)
✕
1,500+ Reviews
from verified clinicians and learners →
Not all ADHD assessor training is equal. The growth in demand for ADHD assessments across the UK and internationally has led to a corresponding growth in training courses. Some are grounded in robust clinical evidence, delivered by experienced practitioners and governed by clear quality assurance processes. Others are not. For a healthcare professional choosing where to invest their time, money and professional development, the ability to distinguish between the two is essential.
Clinical credibility in ADHD training is not simply a matter of prestige or brand recognition. It refers to the extent to which a training programme genuinely prepares clinicians to conduct assessments that are accurate, consistent, evidence-based and defensible. A clinically credible course produces clinicians who can work safely within their scope of practice and who can account for their clinical reasoning at every stage of the assessment process.
This article examines the specific features that make ADHD assessor training clinically credible. It is written for registered healthcare professionals who are evaluating training options and who want to understand what questions to ask, what standards to look for, and why each of those standards matters in clinical practice.
Global ADHD Network designs its ADHD assessor training to meet the standards set out in this article. To learn more about our clinical governance and course content, visit Global ADHD Network
ADHD assessment is a high-stakes clinical process. A diagnosis of ADHD carries significant implications for the person being assessed. It can affect their access to medication, their eligibility for workplace adjustments, their educational support entitlements and their understanding of their own cognitive and emotional functioning. A misdiagnosis, whether false positive or false negative, has real consequences.
This means that the quality of the clinician conducting the assessment matters enormously. And the quality of the clinician is, in significant part, a function of the quality of the training they have received. A clinician who has completed a superficial or poorly governed ADHD training course is more likely to miss important differential diagnoses, to apply diagnostic criteria inconsistently, or to produce reports that do not accurately reflect the clinical picture.
Clinically credible training reduces these risks. It equips clinicians with the knowledge, skills and frameworks they need to conduct assessments that are thorough, consistent and grounded in current evidence. It also gives clinicians the confidence to recognise the limits of their competence and to seek supervision or refer on when a presentation exceeds those limits.
For the healthcare professional choosing a training course, asking questions about clinical credibility is not an optional extra. It is a core part of due diligence.
Clinical governance refers to the systems and processes by which an organisation maintains and improves the quality of its clinical activity. In the context of ADHD training, it means the structures that ensure courses are developed to a defined standard, reviewed regularly, delivered by appropriately qualified faculty, and updated when evidence or guidance changes.
A training provider with strong clinical governance will be able to answer the following questions clearly and without evasion:
A provider that cannot answer these questions, or that answers them vaguely, should be treated with caution. Clinical governance is not a bureaucratic overhead. It is the mechanism that keeps training safe and evidence-based over time.
Strong governance also means that a training programme does not become outdated. ADHD diagnostic practice evolves. The publication of ICD-11, ongoing research into presentation differences across gender, age and neurodevelopmental overlap, and updates to NICE guidance all require training content to be kept current. A governance structure that includes regular curriculum review is the only reliable way to achieve this.
Clinicians can also review the NHS framework for clinical governance to understand how these principles apply across healthcare settings. The
NHS guidance on clinical governance sets out the principles that underpin quality assurance in NHS services, and the same principles should be visible in any reputable clinical training provider.
One of the clearest indicators of a credible training programme is the transparency of its faculty. A clinically credible course will name its trainers, provide their professional registrations and clinical backgrounds, and make clear what their specific expertise in ADHD is.
This matters for several reasons. First, clinicians are entitled to know who is teaching them. When attending medical or clinical education, the professional background of the trainer directly affects the quality of the learning experience. A trainer who is a practising ADHD specialist brings clinical currency and real-world insight that a trainer without direct clinical experience in ADHD cannot replicate.
Second, named faculty with visible professional registrations are accountable. They can be verified. Clinicians can confirm that they are registered with the relevant regulatory body and that they are in good standing. Anonymous or unnamed trainers, or trainers whose qualifications are described only in general terms, offer no such assurance.
Third, the presence of clinical oversight means that the training programme is not solely dependent on the judgement of a single individual. A course with a named clinical director and an advisory board has a structure for challenge and review that a solo trainer or a non-clinical training company does not.
When reviewing a course, clinicians should look for:
Providers who are reluctant to share this information, or who present only partial details, should prompt further scrutiny before enrolment.
A clinically credible ADHD assessor training programme is grounded in current diagnostic frameworks and clinical guidelines. In the UK, this means three primary sources of evidence: the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); the International Classification of Diseases, Eleventh Revision (ICD-11); and the NICE guideline on ADHD.
DSM-5 is widely used in clinical practice for ADHD diagnosis, both in the UK and internationally. It provides specific diagnostic criteria covering inattentive, hyperactive-impulsive and combined presentations, and it specifies requirements relating to age of onset, duration, pervasiveness across settings and degree of functional impairment. Clinicians trained in ADHD assessment need a thorough working knowledge of DSM-5 criteria, including how to apply them to adults and how to account for presentations that do not fit neatly into a single category.
ICD-11 introduced the concept of attention deficit hyperactivity disorder across a broader dimensional framework and aligned more closely with DSM-5 than its predecessor. Clinicians working within NHS settings or internationally should be familiar with ICD-11 criteria and with the differences between the two classification systems.
NICE Guideline NG87, published by the National Institute for Health and Care Excellence, sets out the standards for ADHD diagnosis and management in the UK. It covers assessment processes, the use of structured interview tools, the importance of collateral history, medication prescribing thresholds, shared care arrangements and monitoring requirements. Any training programme that does not reference and align with NICE guidance cannot be considered credible for UK clinical practice.
Clinicians can access the full NICE guideline at
NICE Guideline NG87: Attention Deficit Hyperactivity Disorder, which provides the definitive standards against which assessor competence should be measured.
A training programme should not merely mention these frameworks. It should teach clinicians how to apply them in practice, how to interpret ambiguous presentations against the criteria, and how to document their reasoning in a way that demonstrates engagement with the relevant guidance.
The clinical credibility of ADHD assessor training is perhaps most clearly tested in its treatment of differential diagnosis and comorbidity. These are the areas that separate a superficial awareness course from a genuinely rigorous training programme, and they are the areas that most directly affect patient safety.
Differential diagnosis in ADHD assessment requires clinicians to consider a wide range of conditions that can produce symptoms overlapping with those of ADHD. These include:
Comorbidity adds a further dimension. Many individuals who present for ADHD assessment have more than one condition present simultaneously. Anxiety and ADHD commonly co-occur. Autism and ADHD co-occur at a substantial rate, with research consistently showing that a significant proportion of autistic individuals also meet diagnostic criteria for ADHD. Depression, sleep disorders and substance use disorders are all elevated in prevalence among adults with ADHD.
A credible training programme teaches clinicians how to hold this complexity, how to gather information that allows competing hypotheses to be tested, and how to document a formulation that is honest about uncertainty where it exists. Training that presents ADHD diagnosis as a straightforward checklist exercise is not preparing clinicians adequately for the clinical reality they will encounter.
Report writing is a core clinical competency in ADHD assessment, and its inclusion in a training programme is a strong indicator of clinical seriousness. A course that does not address report writing is preparing clinicians only partially for the work they will do.
The ADHD assessment report is the document that captures and communicates the outcome of the diagnostic process. It must reflect the clinical reasoning that led to the conclusion, document the evidence gathered, address differential diagnoses considered, and make clear recommendations for management and support. It is also, in many contexts, a legally significant document. Reports are used by employers, educational institutions, other clinicians and benefits assessment services. The clarity, accuracy and completeness of the report have real-world consequences for the individual who received the assessment.
Training in report writing should cover:
Training that includes annotated example reports, practice writing exercises and tutor feedback is more likely to produce clinicians who write well and who understand the clinical and professional significance of their reports.
Structured clinical reasoning is closely related to report writing. It refers to the cognitive process by which a clinician gathers information, weighs evidence and reaches a clinical conclusion. Training that teaches structured reasoning, rather than intuitive or impression-based judgement, produces assessments that are more consistent, more accurate and more defensible. Case-based learning is one of the most effective methods for developing structured clinical reasoning, because it requires clinicians to apply their knowledge to complex and realistic scenarios rather than simply to recall information.
A training programme that does not address scope of practice is not fully credible, regardless of the quality of its clinical content. This is because the ability to conduct an ADHD assessment is not solely a matter of knowledge and skill. It is also a matter of professional authority, governance and accountability.
Scope of practice refers to the range of activities that a registered healthcare professional is authorised to perform, based on their professional registration, their training, their employer's governance arrangements and, in some cases, specific legislative or commissioning frameworks. In the context of ADHD diagnosis, scope of practice determines who can diagnose, under what conditions, and with what level of supervision or oversight.
The picture varies significantly across professional groups. A consultant psychiatrist working within an NHS ADHD service operates with a different scope of practice than a mental health nurse working in private practice. A clinical psychologist may be authorised to conduct ADHD assessments within one employer's framework but not another's. A GP may recognise ADHD and initiate a referral without conducting a formal diagnostic assessment.
A credible training programme is honest about this complexity. It does not imply that course completion confers diagnostic authority. It actively helps clinicians understand that the authority to diagnose depends on factors beyond training alone, and it encourages clinicians to seek explicit confirmation from their employer and professional body before conducting independent assessments.
This honesty is not a limitation. It is a mark of clinical seriousness. Training providers who overstate what their course enables clinicians to do are not serving their learners or the patients those learners will go on to assess.
One way to evaluate the credibility of a training programme is to look at what happens to clinicians after they complete it. Credible training produces measurable improvements in clinical knowledge, assessment confidence and the quality of clinical outputs. Providers who collect and share outcome data are demonstrating a commitment to accountability that less rigorous providers may not share.
Useful learner outcome measures in ADHD training include:
Not all providers will have data on all of these measures. But the most credible providers will have thought carefully about learner outcomes, will have some evidence that their training produces meaningful change, and will be willing to share that evidence with prospective learners.
Clinician testimonials and reviews are a related form of evidence. Reviews from registered healthcare professionals who describe specific improvements in their clinical practice are more informative than general endorsements. When reading reviews, clinicians should look for specificity: does the reviewer describe what they learned, how it changed their practice, and what they felt more confident doing after training?
Transparency is a fundamental characteristic of a credible training provider. Transparency means being honest about what a course covers, what it does not cover, who delivers it, how it is governed, what the accreditation means and what completing the course enables clinicians to do.
Accreditation deserves particular attention. In the training market, accreditation claims vary widely in what they actually represent. Some accreditation schemes assess the administration of a course, its learning objectives and its feedback processes, but do not assess the clinical accuracy or depth of the curriculum. Others provide meaningful external review of course content by qualified clinical peers. The difference matters.
Clinicians should ask:
A provider who answers these questions openly and in full is behaving with the transparency that clinical credibility requires. A provider who deflects, provides vague answers, or makes accreditation claims without supporting detail should prompt further scrutiny.
Honest communication extends to course descriptions, marketing materials and learning outcomes. A credible provider describes its course accurately and does not make claims that overstate what clinicians will be able to do following training. If a course description implies that completion alone qualifies a clinician to diagnose ADHD independently, that is a red flag, not a selling point.
Clinical learning does not end when a training course concludes. The most credible ADHD training providers recognise this and offer structured post-course support that helps clinicians consolidate their learning, apply it in practice and continue to develop over time.
Post-course support might take several forms:
The availability of post-course support is particularly important for clinicians who are new to ADHD assessment or who are moving into independent practice following a period of supervised work. The transition from training to independent clinical activity is a period of elevated risk, and support structures that span this transition directly reduce that risk.
A training provider that has no post-course offer is implicitly treating training as a discrete event rather than as part of a broader developmental process. For a complex clinical skill like ADHD assessment, this is insufficient.
Global ADHD Network has built its training programmes around the principles of clinical credibility described throughout this article. Our ADHD assessor training is developed and delivered by practising clinicians with direct experience in ADHD assessment and diagnosis. Our faculty are named, registered and clinically active.
Our curriculum is grounded in DSM-5, ICD-11 and NICE Guideline NG87. We review our content regularly against current evidence and update it when guidance changes. Our governance structure includes a named clinical board with defined responsibilities for curriculum quality, trainer standards and learner safety.
We teach differential diagnosis and comorbidity in depth, using case-based scenarios drawn from real clinical presentations. We include structured report writing training with worked examples and opportunities for practice and feedback. We are explicit about scope of practice throughout our courses, and we actively support clinicians in understanding what governance structures they need to have in place before conducting independent assessments.
We also maintain post-course support for our learners, including access to clinical resources and opportunities for ongoing professional development within our network.
To explore our ADHD assessor training and view upcoming course dates, visit Global ADHD Network ADHD Assessor Training.
To read about our clinical governance, advisory board and accreditation, visit Global ADHD Network
How can I tell if an ADHD training course is clinically credible?
Look for named faculty with verifiable professional registrations, a curriculum grounded in DSM-5, ICD-11 and NICE guidance, transparent governance including a named clinical board, clear accreditation with detail on what it covers, and honest communication about scope of practice. Providers who answer your questions fully and without evasion are more likely to be delivering credible training.
Does accreditation guarantee clinical credibility?
Not automatically. Accreditation schemes vary significantly in what they assess. Some focus on administrative processes and learning objectives without reviewing clinical content in depth. Before treating accreditation as a mark of clinical quality, check who the accrediting body is, what their review process involves, and whether the accreditation is recognised by your own professional regulatory body.
What should I look for in ADHD training faculty?
Look for named trainers with visible professional registrations and a described background in ADHD clinical practice. The most credible faculty are practising clinicians who bring current, real-world experience to their teaching. Trainers whose qualifications are described only in general terms, or who are not named at all, offer fewer assurances.
Is NICE guidance the main standard for ADHD assessment in the UK?
NICE Guideline NG87 is the primary clinical standard for ADHD diagnosis and management in the UK. Any credible ADHD training programme for UK clinicians should be explicitly aligned with this guidance. Clinicians can review the full guideline on the NICE website to understand the standards their training should be preparing them to meet.
What is the difference between clinical governance and accreditation?
Clinical governance refers to the internal systems by which a training provider maintains and improves the quality of its courses. Accreditation refers to external review by a recognised professional body. Both matter. Strong clinical governance ensures that quality is built into the course from the inside. Accreditation provides external validation of that quality. The two are complementary, and the strongest providers will have both.
Does Global ADHD Network offer post-course support?
Yes. Global ADHD Network offers post-course support to help clinicians consolidate their learning and continue to develop their ADHD assessment competence. This includes access to clinical resources and opportunities to engage with our professional network. Find out more at Global ADHD Network.
Clinical credibility in ADHD assessor training is not a vague or subjective quality. It is the product of specific, identifiable features: named and qualified faculty, robust governance structures, curriculum grounded in DSM-5, ICD-11 and NICE guidance, thorough treatment of differential diagnosis and comorbidity, explicit scope of practice education, and honest and transparent communication with prospective learners.
For healthcare professionals choosing where to invest in ADHD training, understanding these features and asking the right questions before enrolling is an act of professional responsibility. The quality of the training you receive will shape the quality of the assessments you conduct and, ultimately, the accuracy of the diagnoses your patients receive.
Global ADHD Network is committed to delivering ADHD assessor training that meets every one of these standards. Our courses are designed for healthcare professionals who take clinical quality seriously and who want training that genuinely prepares them for the complexity of real-world ADHD assessment. To find out more, visit Global ADHD Network ADHD Assessor Training.
